Distribution and migration of mesenchymal stem cells after intravenous transplantation in rats with spinal cord injury
Bai Jin-zhu,Wang Yan,Liu Zhong-jun,Xu Guang-hui,Weimin Ding,Shen Li,Fan Wang,Tian Jia-he
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.25.014
2006-01-01
Abstract:AIM: To explore the feasibility of 67Ga-Oxine labeling of mesenchymal stem cells (MSCs), and determine MSCs distribution and migration after intravenous transplantation in spinal cord-injured rats. METHODS: The experiment was conducted in the Stem Cells Research Center of Peking University between January 2004 and January 2005. ①MSCs were isolated from human umbilical cord blood and labeled with 67Ga-Oxine and Hoechst33342 in vitro. ②Forty SD rats were randomly divided into 2 groups: Experiment group (subjected to spinal cord injury, n=20) and control group (normal rats, n=20), which were injected the same 67Ga-Oxine labeled MSCs suspension into tail vein. ③Rats were killed at 1 day and 1 week after transplantation. The wet weights and radioactivity of various fresh tissues (spinal cord, lung, liver, spleen, kidney, bone marrow, and venous blood) were measured with Gamma Count Meter to calculate the ratios of radioactivity in unit weight of lung, liver, spleen, kidney and bone marrow to venous blood, respectively. The ratios of radioactivity of injured spinal cord and the normal spinal cord at the same site of the control group to adjacent normal spinal cord were also determined, respectively. The ratios were compared between the two groups. The various tissues were sectioned on a freezing microtome to observe the distribution of Hoechst33342-labeling cells in each tissues by Olympus fluorescent microscope. RESULTS: All the 40 rats were involved in the result analysis. ①MSCs labeling efficiency with 67Ga-Oxine was 82.5% in vitro, resulting in an radioactivity of approximately 15.26 MBq/106 cells; The cells survival rate was > 95% tested at 48 hours after labeling. ②The ratios of radioactivity in unit weight of lung, liver, spleen, bone marrow and kidney to venous blood respectively in the experiment group had no significant difference compared with the control group at 1 day and 1 week after transplantation (P > 0.05). The ratios of radioactivity of injured spinal cord to adjacent normal spinal cord of the experiment group had no obvious differences at 1 day after transplantation (P > 0.05), but were significantly higher at 1 week after transplantation compared with the control group (1.441±0.038, 1.003±0.022, P < 0.01). ③Fluorescent observation of sections showed that high initial MSCs with Hoechst33342 labeling occurred in the lungs and increased in the livers, spleens and bone marrows, which could last for 1 week. Appreciable accumulation of cells with label were not found in the spinal cord at 1 day after transplantation, but occurred in the injured spinal cord of the experiment group and mainly gathered in gray matter 1 week later. CONCLUSION: 67Ga-Oxine radiolabelling of MSCs is feasible, and can provides evidence for radionuclide imaging to track implanted MSCs. MSCs may migrate to the injured spinal cord after intravenous transplantation, which provides a non-invasive method for treatment of spinal cord injury with MSCs transplantation.